Latest filing published 08 Jan 2024 for SpringWorks Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
L. Mary Smith: trading record in brief
This profile gathers the share dealings of L. Mary Smith in SpringWorks Therapeutics, Inc., where the filings describe the role as senior executive. In total, 22 filings cover trades dated from 7 January 2021 to 8 January 2024.
Every open-market trade on record is a sale: 4 sales worth €2.4M. The rest of the record consists of 13 share grants and 5 option exercises.
The newest entry dates from 8 January 2024: a share grant of €76k, in SpringWorks Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to L. Mary Smith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 21,156 shares0Common StockSEC:0001104659-24-002380:0
- 5,720 sharesCommon StockSEC:0001104659-23-078084:0
- 1,068 shares@ US$26.416.1% of flowCommon StockSEC:0001104659-23-002695:0
- 22,663 sharesCommon StockSEC:0001104659-23-002318:0
- 1,551 shares@ US$28.479.8% of flowCommon StockSEC:0001104659-22-081242:0
- 6,092 shares0Common StockSEC:0001104659-22-077448:0
- 1,181 shares@ US$56.0622.9% of flowCommon StockSEC:0001104659-22-004463:0
- 1,772 shares@ US$56.0634.3% of flowCommon StockSEC:0001104659-22-003144:0
- 22,205 sharesCommon StockSEC:0001104659-22-002747:0
- 10,000 shares@ US$2.307.7% of flowCommon StockSEC:0001104659-21-125932:0
- 10,000 shares@ US$2.307.6% of flowCommon StockSEC:0001104659-21-092123:0
11 of 11 declarations
